245 related articles for article (PubMed ID: 21179185)
1. HIV vaccine efficacy trials: A brief history, and options for going forward.
McKinnon LR; Card CM;
AIDS Rev; 2010; 12(4):209-17. PubMed ID: 21179185
[TBL] [Abstract][Full Text] [Related]
2. HIV vaccine efficacy trials: towards the future of HIV prevention.
Kim D; Elizaga M; Duerr A
Infect Dis Clin North Am; 2007 Mar; 21(1):201-17, x. PubMed ID: 17502236
[TBL] [Abstract][Full Text] [Related]
3. Current strategies and limitations of HIV vaccines.
Kawalekar OU; Shedlock DJ; Weiner DB
Curr Opin Investig Drugs; 2010 Feb; 11(2):192-202. PubMed ID: 20112169
[TBL] [Abstract][Full Text] [Related]
4. Statistical evaluation of HIV vaccines in early clinical trials.
Moodie Z; Rossini AJ; Hudgens MG; Gilbert PB; Self SG; Russell ND
Contemp Clin Trials; 2006 Apr; 27(2):147-60. PubMed ID: 16426900
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic vaccine trails in Thailand.
Churdboonchart V
J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
[TBL] [Abstract][Full Text] [Related]
6. Don't stop me now.
Nat Immunol; 2008 Aug; 9(8):821. PubMed ID: 18645584
[No Abstract] [Full Text] [Related]
7. Broadening inclusion of vulnerable populations in HIV vaccine trials.
Lau CY; Cardinali M; Sato PA; Fix A; Flores J
Expert Rev Vaccines; 2008 Mar; 7(2):259-68. PubMed ID: 18324894
[TBL] [Abstract][Full Text] [Related]
8. HIV/AIDS vaccines: a need for new concepts?
Girard MP; Bansal GP
Int Rev Immunol; 2008; 27(6):447-71. PubMed ID: 19065351
[TBL] [Abstract][Full Text] [Related]
9. Assessment of mucosal immunity to HIV-1.
Jespers V; Harandi AM; Hinkula J; Medaglini D; Le Grand R; Stahl-Hennig C; Bogers W; El Habib R; Wegmann F; Fraser C; Cranage M; Shattock RJ; Spetz AL
Expert Rev Vaccines; 2010 Apr; 9(4):381-94. PubMed ID: 20370549
[TBL] [Abstract][Full Text] [Related]
10. HIV vaccine development: Lessons from the past, informing the future.
Bradac J; Dieffenbach CW
IDrugs; 2009 Jul; 12(7):435-9. PubMed ID: 19579164
[TBL] [Abstract][Full Text] [Related]
11. Future paths for HIV vaccine research: Exploiting results from recent clinical trials and current scientific advances.
Bansal GP; Malaspina A; Flores J
Curr Opin Mol Ther; 2010 Feb; 12(1):39-46. PubMed ID: 20140815
[TBL] [Abstract][Full Text] [Related]
12. Towards the development of a therapeutic vaccine for the treatment of HIV-1 infection: are we closer than ever?
Egan MA
Expert Rev Vaccines; 2007 Jun; 6(3):289-91. PubMed ID: 17542741
[No Abstract] [Full Text] [Related]
13. Obstacles and progress toward development of a preventive HIV vaccine.
Heyward WL; MacQueen KM; Jaffe HW
J Int Assoc Physicians AIDS Care; 1997 Aug; 3(8):28-34. PubMed ID: 11364630
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 vaccine clinical trials: the Brazilian experience.
Ersching J; Pinto AR
Rev Med Virol; 2009 Sep; 19(5):301-11. PubMed ID: 19650156
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with therapeutic AIDS vaccines.
Bourinbaiar AS; Abulafia-Lapid R
Expert Rev Vaccines; 2005 Jun; 4(3):289-304. PubMed ID: 16026245
[TBL] [Abstract][Full Text] [Related]
16. A brief history of the global effort to develop a preventive HIV vaccine.
Esparza J
Vaccine; 2013 Aug; 31(35):3502-18. PubMed ID: 23707164
[TBL] [Abstract][Full Text] [Related]
17. HIV-1/AIDS vaccine development: are we in the darkness.
Qiu C; Xu JQ
Chin Med J (Engl); 2008 May; 121(10):939-45. PubMed ID: 18706210
[No Abstract] [Full Text] [Related]
18. HIV vaccine trials in India.
Berkley S
Nat Biotechnol; 2008 May; 26(5):495; author reply 496. PubMed ID: 18464771
[No Abstract] [Full Text] [Related]
19. Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development.
Heeney JL; Hahn BH
AIDS; 2000; 14 Suppl 3():S125-7. PubMed ID: 11086855
[No Abstract] [Full Text] [Related]
20. Update on HIV vaccines.
Meldorf M; Corey L
STEP Perspect; 1997; 9(2):5-6, 8-9. PubMed ID: 11364929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
